Sol-Gel Technologies Ltd.
IPOHarnessing Dermatological Innovation
Public · Ness Ziona
- Headquarters
- Ness Ziona
- Business Model
- B2B
- Website
- sol-gel.com
- Rounds
- 2
- Type
- Public
About
Sol-Gel Technologies is a NASDAQ-listed (SLGL) dermatology company leveraging proprietary microencapsulation and formulation technology to develop and commercialize advanced treatments for patients with severe and rare skin conditions, including two FDA-approved products, TWYNEO and EPSOLAY. The company's pipeline extends into additional indications such as Gorlin Syndrome and high-frequency basal cell carcinoma, and it partners with established commercial leaders to accelerate global product rollout.
Summary
Sol-Gel Technologies Ltd. is a Biotech company based in Ness Ziona. Investors include Great Point Partners, Squadron Capital and Surveyor Capital.
Funding & Exit History
May 2026
Sign up to see all 6 events
Funding, valuations, and company events, with amounts and investors where available.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/sol-gel-technologies-ltd"><img src="https://indexed.vc/api/badge/company/sol-gel-technologies-ltd" alt="Sol-Gel Technologies Ltd. on Indexed.vc" width="260" height="76" /></a>